Table 2.
Serum 25-hydroxycholecalciferol (25OHD3) concentrations of embryos at 462 h of incubation (hoi) after in ovo injection of a 50 μl solution volume at 432 hoi.
| Treatment | Serum 25OHD3 concentration (ng/mL) |
|---|---|
| Noninjected | 8.61b |
| Diluent1 | 9.74b |
| Vitamin D32 | |
| 0.6 | 8.83b |
| 1.2 | 11.24a |
| 2.4 | 11.60a |
| 25OHD33 | |
| 0.6 | 10.95a |
| 1.2 | 12.10a |
| 2.4 | 12.29a |
| Vitamin D3 + 25OHD34 | |
| 1.2 | 11.41a |
| 2.4 | 10.96a |
| 4.8 | 12.20a |
| Source of variation | |
| Pooled SEM | 0.301 |
| P-value | 0.001 |
a,bMeans within control, vitamin D3, 25OHD3, and vitamin D3 + 25OHD3 categories with no common superscript differ significantly (P < 0.05).
Eggs injected with 50 μl commercial MD diluent at 432 hoi.
Eggs injected with 50 μl commercial MD diluent containing vitamin D3 at 0.6, 1.2, and 2.4 μg at 432 hoi.
Eggs injected with 50 μl commercial MD diluent containing 25OHD3 at 0.6, 1.2, and 2.4 μg at 432 hoi.
Eggs injected with 50 μl commercial MD diluent containing a combination of D3 and 25OHD3 at 1.2, 2.4, and 4.8 μg at 432 hoi.